NCT04442776 (PAI-D) is a NA clinical trial of D-AIP in Diagnosis, Dual (Psychiatry), sponsored by Cardenal Herrera University.

Who is sponsoring NCT04442776?

NCT04442776 is sponsored by Cardenal Herrera University.

What drugs are being tested in NCT04442776?

Interventions in NCT04442776: D-AIP.

What condition does NCT04442776 study?

NCT04442776 studies Diagnosis, Dual (Psychiatry).

Is NCT04442776 still recruiting?

NCT04442776 is currently status unknown. Last updated 23 June 2020.

Last reviewed 2020-06-23 · How we verify

NCT04442776: PAI-D

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dual Integrated Attention Program (DAIP) in People With Severe Dual Diagnosis

Status unknown NA Last updated 23 June 2020

What this trial tests

NA trial testing D-AIP in Diagnosis, Dual (Psychiatry) in 86 participants. Status unknown.

Timeline

1 September 2020

Primary endpoint
1 April 2021

1 May 2023

Quick facts

Lead sponsor	Cardenal Herrera University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	86
Start date	1 September 2020
Primary completion	1 April 2021
Estimated completion	1 May 2023

Drugs / interventions tested

D-AIP

Conditions studied

Diagnosis, Dual (Psychiatry) — all drugs for Diagnosis, Dual (Psychiatry) →

Sponsor

Cardenal Herrera University

Who can join

18 and older, any sex, with Diagnosis, Dual (Psychiatry). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim: validate a Dual Integrated Attention Program (D-AIP) for mental health nursing in people with Severe Dual Diagnosis admitted to a psychiatric hospitalization unit Design: Randomized Controlled Trial. Population: Inpatients with dual diagnosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Cardenal Herrera University trials

Trials by the same sponsor.

NCT07471269 — Online Pain Neuroscience Education For Fear Of Childbirth. · NA · recruiting
NCT07373938 — Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus · recruiting
NCT07499856 — Intradialytic Exercise Program Supported by Audiovisual Media Combined With Mindfulness · NA · enrolling by invitation
NCT07275112 — Cross-cultural an Reliability and Validity Evaluation of TENDINS-A in Spain · completed
NCT07133581 — Design and Validation of FEXO: A Playful Exercise Program for Institutionalized Frail Older Adults · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04442776 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cardenal Herrera University
Last refreshed: 23 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04442776.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing